Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307634724> ?p ?o ?g. }
- W4307634724 endingPage "1575" @default.
- W4307634724 startingPage "1575" @default.
- W4307634724 abstract "PD-(L)1 inhibitor could improve the survival of locally advanced esophageal cancer (ESCA) patients, but we cannot tailor the treatment to common biomarkers. WNT signaling activation was associated with primary resistance to immunotherapy. In this study, we used our two clinical cohorts (BJCH n = 95, BJIM n = 21) and three public cohorts to evaluate and verify a new immunotherapeutic biomarker based on WNT signaling in ESCA patients. Our findings showed that WNT signaling-related genes stratified TCGA patients into Cluster 1, 2, and 3, among which, Cluster 3 had the worst prognosis. The most up- and down-regulated genes in Cluster 3 were IGFBP1 and WNT3A. Further analysis validated that IGFBP1hiWNT3Alo ESCA patients had significantly poor RFS and OS in the TCGA and BJCH cohorts. Interestingly, IGFBP1hiWNT3Alo patients had a good response and prognosis with immunotherapy in three independent cohorts, exhibiting better predictive value than PD-L1 expression (signature AUC = 0.750; PD-L1 AUC = 0.571). Moreover, IGFBP1hiWNT3Alo patients may benefit more from immunotherapy than standard treatment (p = 0.026). Immune cell infiltration analysis revealed a significant increase in DC infiltration in IGFBP1hiWNT3Alo patients post-immunotherapy (p = 0.022), which may enhance immune response. The IGFBP1hiWNT3Alo signature could predict patients who benefited from PD-(L)1 inhibitor treatment and may serve as a biomarker in ESCA." @default.
- W4307634724 created "2022-11-04" @default.
- W4307634724 creator A5001394498 @default.
- W4307634724 creator A5009292019 @default.
- W4307634724 creator A5016611595 @default.
- W4307634724 creator A5020951161 @default.
- W4307634724 creator A5026379419 @default.
- W4307634724 creator A5035769138 @default.
- W4307634724 creator A5038534200 @default.
- W4307634724 date "2022-10-27" @default.
- W4307634724 modified "2023-10-16" @default.
- W4307634724 title "IGFBP1hiWNT3Alo Subtype in Esophageal Cancer Predicts Response and Prolonged Survival with PD-(L)1 Inhibitor" @default.
- W4307634724 cites W1498931318 @default.
- W4307634724 cites W1856892620 @default.
- W4307634724 cites W2013891209 @default.
- W4307634724 cites W2015843482 @default.
- W4307634724 cites W2044821216 @default.
- W4307634724 cites W2050216284 @default.
- W4307634724 cites W2091341060 @default.
- W4307634724 cites W2142531099 @default.
- W4307634724 cites W2145805608 @default.
- W4307634724 cites W2165466723 @default.
- W4307634724 cites W2180091996 @default.
- W4307634724 cites W2322802697 @default.
- W4307634724 cites W2323326409 @default.
- W4307634724 cites W2341604280 @default.
- W4307634724 cites W2345334273 @default.
- W4307634724 cites W2533508881 @default.
- W4307634724 cites W2559382297 @default.
- W4307634724 cites W2586629973 @default.
- W4307634724 cites W2592144107 @default.
- W4307634724 cites W2620603874 @default.
- W4307634724 cites W2793126529 @default.
- W4307634724 cites W2796207838 @default.
- W4307634724 cites W2801312275 @default.
- W4307634724 cites W2804930677 @default.
- W4307634724 cites W2896192438 @default.
- W4307634724 cites W2898751221 @default.
- W4307634724 cites W2899174828 @default.
- W4307634724 cites W2906166963 @default.
- W4307634724 cites W2907262475 @default.
- W4307634724 cites W2909312563 @default.
- W4307634724 cites W292398390 @default.
- W4307634724 cites W2954094199 @default.
- W4307634724 cites W2982392853 @default.
- W4307634724 cites W2984359187 @default.
- W4307634724 cites W3000279920 @default.
- W4307634724 cites W3024820996 @default.
- W4307634724 cites W3025003676 @default.
- W4307634724 cites W3049017521 @default.
- W4307634724 cites W3081630303 @default.
- W4307634724 cites W3082736986 @default.
- W4307634724 cites W3083613542 @default.
- W4307634724 cites W3083986479 @default.
- W4307634724 cites W3092384992 @default.
- W4307634724 cites W3096903097 @default.
- W4307634724 cites W3113868193 @default.
- W4307634724 cites W3123367719 @default.
- W4307634724 cites W3128646645 @default.
- W4307634724 cites W3134553072 @default.
- W4307634724 cites W3148827278 @default.
- W4307634724 cites W3162327115 @default.
- W4307634724 cites W3166418545 @default.
- W4307634724 cites W3198060252 @default.
- W4307634724 cites W3200755631 @default.
- W4307634724 cites W3206113963 @default.
- W4307634724 cites W3211603851 @default.
- W4307634724 cites W4293555829 @default.
- W4307634724 cites W3213894810 @default.
- W4307634724 doi "https://doi.org/10.3390/biology11111575" @default.
- W4307634724 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36358276" @default.
- W4307634724 hasPublicationYear "2022" @default.
- W4307634724 type Work @default.
- W4307634724 citedByCount "1" @default.
- W4307634724 countsByYear W43076347242023 @default.
- W4307634724 crossrefType "journal-article" @default.
- W4307634724 hasAuthorship W4307634724A5001394498 @default.
- W4307634724 hasAuthorship W4307634724A5009292019 @default.
- W4307634724 hasAuthorship W4307634724A5016611595 @default.
- W4307634724 hasAuthorship W4307634724A5020951161 @default.
- W4307634724 hasAuthorship W4307634724A5026379419 @default.
- W4307634724 hasAuthorship W4307634724A5035769138 @default.
- W4307634724 hasAuthorship W4307634724A5038534200 @default.
- W4307634724 hasBestOaLocation W43076347241 @default.
- W4307634724 hasConcept C121608353 @default.
- W4307634724 hasConcept C126322002 @default.
- W4307634724 hasConcept C137620995 @default.
- W4307634724 hasConcept C143998085 @default.
- W4307634724 hasConcept C203014093 @default.
- W4307634724 hasConcept C2777701055 @default.
- W4307634724 hasConcept C2779742542 @default.
- W4307634724 hasConcept C2781197716 @default.
- W4307634724 hasConcept C502942594 @default.
- W4307634724 hasConcept C55493867 @default.
- W4307634724 hasConcept C62478195 @default.
- W4307634724 hasConcept C71924100 @default.
- W4307634724 hasConcept C86803240 @default.
- W4307634724 hasConcept C8891405 @default.